Utilization of the Genexus Turnkey NGS Platform for Molecular Profiling of NSCLC Samples
Explore the application of the Genexus turnkey NGS platform for molecular profiling of non-small cell lung cancer (NSCLC) samples in this informative 19-minute webinar presented by Dr. Brendan Pang, a Consultant Pathologist and Medical/Laboratory Director at Angsana Molecular and Diagnostics and Parkway Laboratory Services Ltd. Gain insights into the latest advancements in next-generation sequencing (NGS) technology and its role in enhancing the molecular characterization of NSCLC. Learn how this innovative platform streamlines the process of genetic profiling, potentially improving diagnostic accuracy and treatment decision-making for NSCLC patients. Discover the potential impact of this technology on personalized medicine approaches in lung cancer management.